57 filings
10-Q
2024 Q1
GPCR
Structure Therapeutics Inc
Quarterly report
9 May 24
4:56pm
8-K
GPCR
Structure Therapeutics Inc
9 May 24
Structure Therapeutics Reports First Quarter 2024 Financial Results and Recent Highlights
4:10pm
ARS
2023 FY
GPCR
Structure Therapeutics Inc
25 Apr 24
Annual report to shareholders
5:24pm
DEF 14A
GPCR
Structure Therapeutics Inc
25 Apr 24
Definitive proxy
4:14pm
S-8
GPCR
Structure Therapeutics Inc
8 Mar 24
Registration of securities for employees
4:19pm
8-K
rbft2195mop8a63r8oy9
8 Mar 24
Structure Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Highlights
8:43am
8-K
7ysvw lpa0ex
18 Dec 23
Regulation FD Disclosure
8:28am
EFFECT
aqdzyswg13nv
30 Nov 23
Notice of effectiveness
12:15am
CORRESP
9ej64fhb7r kjj6j7dy
27 Nov 23
Correspondence with SEC
12:00am
UPLOAD
c98 sdhj8
24 Nov 23
Letter from SEC
12:00am
NT 10-Q
u1vsm8
14 Nov 23
Notice of late quarterly filing
5:19pm
8-K
5sb8fu6f24d zd4d6bww
14 Nov 23
Structure Therapeutics Reports Third Quarter 2023 Financial Results and Recent Highlights
5:17pm
8-K
qs0cunaa5fq0v
29 Sep 23
Share Purchase Agreement
7:50am
8-K
o2gbuh8u2
29 Sep 23
Structure Therapeutics Announces Positive Results from Phase 1b Clinical Study of Oral GLP-1 Receptor Agonist GSBR-1290 and Provides Program Update
7:38am